scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1012740637 |
P356 | DOI | 10.1186/S12974-016-0589-4 |
P932 | PMC publication ID | 4888657 |
P698 | PubMed publication ID | 27245439 |
P50 | author | Marco Vinceti | Q52576882 |
Jessica Mandrioli | Q57233868 | ||
P2093 | author name string | Berta Brodsky | |
Uri Wormser | |||
Nicola Fini | |||
Yoram Finkelstein | |||
Amnon Sintov | |||
Elena Proskura | |||
P2860 | cites work | Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS) | Q81280255 |
Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation? | Q83169004 | ||
Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis | Q84082658 | ||
Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature | Q30580165 | ||
Should health-care systems pay for replacement therapy in patients with alpha(1)-antitrypsin deficiency? A critical review and cost-effectiveness analysis | Q33860662 | ||
Prognostic factors in ALS: A critical review | Q36447824 | ||
Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival | Q36602163 | ||
Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood | Q37159126 | ||
C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex | Q37167781 | ||
Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent | Q37986292 | ||
Inflammation and neurovascular changes in amyotrophic lateral sclerosis. | Q38056551 | ||
The concentration of alpha-1-antitrypsin in cerebrospinal fluid and serum in a series of 40 intracranial tumors | Q40698530 | ||
Cerebrospinal fluid alpha-1-antitrypsin alpha-1-antitrypsin-elastase complex levels in meningitis | Q44292976 | ||
Serpin=serine protease-like complexes within neurofilament conglomerates of motoneurons in amyotrophic lateral sclerosis | Q46286558 | ||
Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. | Q46789821 | ||
Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis | Q47621315 | ||
A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. | Q51864361 | ||
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies. | Q53388392 | ||
P433 | issue | 1 | |
P921 | main subject | cerebrospinal fluid | Q54196 |
amyotrophic lateral sclerosis | Q206901 | ||
P304 | page(s) | 131 | |
P577 | publication date | 2016-06-01 | |
P1433 | published in | Journal of Neuroinflammation | Q15716679 |
P1476 | title | Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment | |
P478 | volume | 13 |
Q41475139 | Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders |
Q64095961 | Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis |
Q46370548 | Elevated Levels of Selenium Species in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients with Disease-Associated Gene Mutations |
Q42278003 | iTRAQ-Based Proteomics of Chronic Renal Failure Rats after FuShengong Decoction Treatment Reveals Haptoglobin and Alpha-1-Antitrypsin as Potential Biomarkers. |
Search more.